Autopsy report · NCT04225819
Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
Cause of deathOther
“Protocol is being modified.”
Life of this trial
- Registered 9 months before it started.
- Suspended: paused, and may or may not restart.
- 100 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- IBD; Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis; Vitamin D3 Deficiency
- Interventions
- Vitamin D3; Placebo
- Participants
- 100 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- RCT for Women With a Persisting Pregnancy of Unknown Location
“A new protocol was written to replace this protocol.” - Epidural Loading: High Volume, Low Concentration
“The protocol will be rewritten.” - Bacteriophage Therapy in Patients With Prosthetic Joint Infections
“Changes to protocol design” - Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
“Replaced by another protocol” - A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee
“To be replaced by a different protocol”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.